Tekla Life Sciences Investors (HQL) Forms $20.53 Double Top; Eulav Asset Management Has Lowered By $950,000 Its Jpmorgan Chase & Co (JPM) Holding

Tekla Life Sciences Investors (HQL) formed double top with $21.56 target or 5.00% above today’s $20.53 share price. Tekla Life Sciences Investors (HQL) has $434.62M valuation. The stock increased 0.64% or $0.13 during the last trading session, reaching $20.53. About 22,396 shares traded. Tekla Life Sciences Investors (NYSE:HQL) has risen 15.63% since January 12, 2017 and is uptrending. It has underperformed by 1.07% the S&P500.

Eulav Asset Management decreased Jpmorgan Chase & Co (JPM) stake by 12.2% reported in 2017Q3 SEC filing. Eulav Asset Management sold 10,000 shares as Jpmorgan Chase & Co (JPM)’s stock declined 6.04%. The Eulav Asset Management holds 72,000 shares with $6.88 million value, down from 82,000 last quarter. Jpmorgan Chase & Co now has $387.79 billion valuation. The stock increased 0.85% or $0.94 during the last trading session, reaching $111.78. About 8.44 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since January 12, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Investors sentiment increased to 1.57 in Q3 2017. Its up 0.07, from 1.5 in 2017Q2. It improved, as 5 investors sold Tekla Life Sciences Investors shares while 9 reduced holdings. 8 funds opened positions while 14 raised stakes. 2.35 million shares or 9.57% more from 2.14 million shares in 2017Q2 were reported. Lpl Fincl Llc holds 114,626 shares or 0.01% of its portfolio. Sei Invests Company reported 0% stake. Morgan Stanley reported 0% stake. Ameriprise holds 0% or 19,895 shares in its portfolio. Jfs Wealth Advisors Limited Liability Co reported 3 shares. New England Private Wealth Ltd Limited Liability Company holds 12,291 shares. Cohen And Steers Inc holds 0.01% in Tekla Life Sciences Investors (NYSE:HQL) or 92,368 shares. The Illinois-based Blair William Il has invested 0.01% in Tekla Life Sciences Investors (NYSE:HQL). Pennsylvania-based Pnc Financial Services has invested 0% in Tekla Life Sciences Investors (NYSE:HQL). Valley Natl Advisers accumulated 3,029 shares or 0.02% of the stock. Advisory Services Ntwk Ltd Liability Corporation has 2,519 shares for 0.01% of their portfolio. Oppenheimer And Com Inc holds 26,600 shares. Creative Planning has 11,099 shares for 0% of their portfolio. The California-based Wells Fargo And Mn has invested 0% in Tekla Life Sciences Investors (NYSE:HQL). Janney Montgomery Scott Ltd Com owns 0.01% invested in Tekla Life Sciences Investors (NYSE:HQL) for 21,537 shares.

Since August 21, 2017, it had 0 insider purchases, and 2 insider sales for $1.12 million activity. Shares for $214,019 were sold by Friedman Stacey.

Eulav Asset Management increased Home Depot Inc (NYSE:HD) stake by 4,000 shares to 24,000 valued at $3.93M in 2017Q3. It also upped Zendesk Inc (NYSE:ZEN) stake by 21,600 shares and now owns 341,600 shares. Littelfuse Inc (NASDAQ:LFUS) was raised too.

Among 32 analysts covering JPMorgan Chase & Co (NYSE:JPM), 17 have Buy rating, 2 Sell and 13 Hold. Therefore 53% are positive. JPMorgan Chase & Co had 99 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating by UBS given on Monday, January 18. Ertse Group downgraded the stock to “Hold” rating in Monday, April 25 report. Jefferies maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Monday, October 10. Jefferies has “Buy” rating and $77 target. The firm has “Buy” rating given on Wednesday, October 14 by Argus Research. The firm earned “Outperform” rating on Thursday, August 10 by Wells Fargo. On Tuesday, August 25 the stock rating was upgraded by Credit Agricole to “Outperform”. As per Thursday, July 20, the company rating was maintained by Oppenheimer. Robert W. Baird maintained the shares of JPM in report on Wednesday, November 15 with “Hold” rating. As per Wednesday, October 14, the company rating was maintained by Keefe Bruyette & Woods. The rating was upgraded by Buckingham Research on Thursday, December 21 to “Buy”.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: